Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease

Go back to Clearmind Medicine Announces Publication of International Patent for Novel Therapy Targeting Weight Loss and Fatty Liver Disease
(NASDAQ: CMND) Delayed: 3.34 --0 (-0%)
Previous Close $3.34    52 Week High
Open $3.28    52 Week Low
Day High $3.55    P/E N/A 
Day Low $3.26    EPS
Volume 163,903       

(NASDAQ: SPRC) Delayed: 8.55 -0.76 (8.16%)
Previous Close $9.31    52 Week High
Open $9.05    52 Week Low
Day High $9.23    P/E N/A 
Day Low $8.40    EPS
Volume 24,335